Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.06
+0.07 (1.17%)
Sep 30, 2026, 4:08 PM HKT

HKG:1167 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
513.64-145.98-155.71-359.12-371.86-301.19
Depreciation & Amortization
22.6622.8126.4625.0813.810.79
Loss (Gain) From Sale of Assets
-19.17-19.170.14-0.63--
Loss (Gain) From Sale of Investments
0.90.90.027.24-4.19-0.19
Loss (Gain) on Equity Investments
0.530.53----
Stock-Based Compensation
4.484.489.9614.8616.9919.45
Other Operating Activities
75.66-0.98-32.06-38.48-79.0715.25
Change in Accounts Receivable
-1.16-1.161.665.6979.0789.03
Change in Accounts Payable
-72.59-72.5936.77-15.3645.522.77
Change in Unearned Revenue
-0.41-0.41-0.42-0.42-0.42-3.24
Change in Other Net Operating Assets
0.530.5339.06-3.077.75-0.16
Operating Cash Flow
525.07-211.05-74.12-364.2-292.42-147.49
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.04-1.1-12.09-37.83-16.44-10.11
Sale of Property, Plant & Equipment
986.52986.520.261.730.090.01
Sale (Purchase) of Intangibles
-0.53-0.57--0.83-0.06-1.03
Investment in Securities
-1,817-1,127217.47-27.71-667.47178.76
Other Investing Activities
26.8924.950.5917.25-2.43-5.97
Investing Cash Flow
-805.12-117.42256.22-47.39-686.32161.67

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-114.8787.773.62--
Total Debt Issued
139.04114.8787.773.62--
Long-Term Debt Repaid
--102.19-100.28-13.5-7.6-11.37
Lease Payments
-10.23-10.02-11.02-13.5-7.6-11.37
Total Debt Repaid
-123.24-102.19-100.28-13.5-7.6-11.37
Net Debt Issued (Repaid)
15.812.68-12.5860.12-7.6-11.37
Issuance of Common Stock
-4545199.14-132.83
Repurchase of Common Stock
-31.85-11.28-4.57-5.68--
Other Financing Activities
-4.96-5-6.58-7.91-2.26-12.41
Financing Cash Flow
-21.0141.4121.28245.66-9.85109.06

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-26.3-16.264.5510.785.77-26.44
Net Cash Flow
-327.36-303.32207.94-155.22-902.8396.79

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
524.03-212.15-86.21-402.03-308.86-157.6
Free Cash Flow Growth
------
Free Cash Flow Margin
70.94%-396.35%-55.37%-632.92%-322.58%-103.13%
Free Cash Flow Per Share
0.68-0.27-0.11-0.52-0.41-0.21
Levered Free Cash Flow
488.19-58.42-41.72-267.43-158.82-67.48
Unlevered Free Cash Flow
495.07-50.34-36.47-262.23-157.41-67.12
Free Cash Flow After Leases
513.8-222.17-97.23-415.52-316.46-168.97

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
4.9656.587.912.260.51
Change in Working Capital
-73.63-73.6377.07-13.15131.92108.4